cell migration/invasion in breast cancer
Reprimo as a modulator of cell migration and invasion in the MDA MB 231 breast cancer cell line
... predominantly in the cytoplasm [6]. Nevertheless, in silico gene ontology analysis of its amino acid sequence show that RPRM is an integral com- ponent of cell membrane (URL: ...complex in ...
10
Regulatory Effects of Linc00486 on Biological Characteristics of Breast Cancer Cells
... of cell proliferation- related proteins were determined by Western blotting to explore the mechanism by which LINC00486 affected the proliferation of ...the cell cycle, inhibit the cell cycle ...
8
Functional characterization of E- and P-cadherin in invasive breast cancer cells
... calcium-dependent cell-cell adhesion [1]. Their genes cluster in specific chromosomal regions, such as human ...differences in tissue expression and function ...expressed in the luminal ...
14
HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.
... involved in tumor progression through increased cell proliferation, invasion and angiogenesis ...necessary in order to determine if the inhibition of AKT phosphorylation induced by Bozepinib ...
17
Título26,26,26,27,27,27 Hexadeuterated 1,25 Dihydroxyvitamin D3 (1,25D d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines
... various cell types. This has led to the study of its properties in several processes such as cancer ...[1–4]. In breast cancer 1,25D and some of its analogues inhibit cycle ...
12
Anti neoplastic drugs increase caveolin 1 dependent migration, invasion and metastasis of cancer cells
... to cancer are aberrant DNA methylation and covalent histone modifications ...enriched in CpG islands that are not methylated in normal breast epithelial cells and express higher levels of ...
23
Genetic Cancer Risk Assessment for Breast Cancer in Latin America
... America, breast cancer is the most common malignancy in women, and limited available data suggest that up to 15% of all breast cancer cases in the region are ...Genetic ...
9
Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles.
... PBCA NPs (ie, with no DOX loading, and at similar dilutions to drug-loaded NPs). Cytotoxic activity was assessed by deter- mining the 50% inhibitory concentration (IC 50 ) values obtained from the ...
16
Immunotherapy for the Treatment of Cancer pdf
... obtained in the case of haematological tumours are not reproducible in solid ...tumours. In addition, today, "cell therapy" costs hundreds of thousands of dollars per ...time. ...
8
HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma
... plated in 24 well plates with regular media and harvested after 24, 48 and 72 h for measurement of proliferation by staining the wells with crystal ...stain in methanol for 2–3 h, and the plates were read ...
15
Análisis de vídeos sobre cáncer de mama en YouTube
... videos in this stage of the content analysis, we used inductive coding (Andréu, 2002) because –due to the variety of the material and its specificity– no sources were found with classifications that fit the ...
15
Familial Breast Cancer in Costa Rica: An initial approach
... American Cancer Society calculates 215 990 new cases of breast cancer occurring among women in 2004, and estimates 40 580 deaths due to breast cancer within the popula- tion of ...
6
Beyond Breast Cancer In Later Life: Subjective Well-Being In Older Women With Breast Cancer In Remission
... estudio. In- vestigaciones futuras deberían tener en cuenta estas limitaciones de modo tal de comprender cabalmente las relaciones entre cáncer de mama en remisión y BS entre adultas mayores para empoderar ...
8
Evaluación de biomarcadores en carcinoma ductal in situ de mama: expresión inmunohistoquímica y correlación clinicopatológica
... inmunohistoquímicos han demostrado inmunoreactividad de membrana para el oncogén HER-2 entre el 42% al 61% de los CDIS. La amplificación del gen HER-2 ha sido reportada entre el 40% al 48% de los casos de CDIS aislados ...
251
Caracterización fitoquímica y actividad antiproliferativa de extractos de hoja de Ficus crocata en la línea celular MDA-MB-231
... on cancer cells and may be used as adjuvants therapy in cancer ...conducted in the Ficus genus show the great anti-carcinogenic potential of its species [17, 18, 19, 20, 32, 39], and it has ...
36
Minería de datos sobre los factores de riesgo del cáncer de mama
... 2.3.2 Breast cancer gene Factores de riesgo genéticos: Gene symbol Genes Freq BRCA1 breast cancer 1, early onset 5467 BRCA2 breast cancer 2, early onset 2981 TP53 tumor protein p53 732 E[r] ...
45
Hormona liberadora de la hormona del crecimiento (GHRH) y sus antagonistas en la progresión del cáncer de próstata
... estudios in vitro e in vivo, en los que se ha demostrado una significativa supresión del crecimiento de varios cánceres experimentales: próstata (Fahrenholtz y ...potentes, in cluso uno de los ...
277
Social inequalities and mortality in Europe-results from a large multi-national cohort
... Unit, Cancer Research and Prevention Institute, Florence, Italy, 28 Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy, 29 Cancer Registry and Environmental ...
10
Psychological Distress in Lithuanian Women with Breast Cancer
... El listado de problemas fue desarrollado por el Panel de Guías para el Manejo del malestar de la NCCN (National Comprehensive Cancer Network, 2003). Consiste en 34 problemas asociados con aflicciones comúnmente ...
8
Cncer injertado en tejido mamario ectpico
... tissue. In both of them, malignant tumors of the breast can proliferate, mostly in aberrant ...gland in the left submammary that never caused discomfort to the last two months when its volume ...
5